Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance)
Article 1
In force · version of Oct 8, 2023
In Part D of the Annex of Implementing Regulation (EU) No 686/2012, the following entry is inserted after the entry for ‘Cyantraniliprole’:
Active substance Rapporteur Member State Co-rapporteur Member State ‘Etoxazole FR EL’